Become a fan of Slashdot on Facebook

 



Forgot your password?
typodupeerror
×
Biotech Science Technology

Synthetic Molecules Emulate Enzyme Behavior 58

FiReaNGeL writes "Ohio State University chemists have created a synthetic catalyst that can fold its molecular structure into a specific shape for a specific job, similar to natural catalysts. In tests, the chemists caused the catalysts to twist one way or the other, either to form one chemical product or its mirror image. They confirmed the shape of the molecules at each step using techniques such as nuclear magnetic resonance spectroscopy. Being able to quickly produce a catalyst of a particular shape would be a boon for the pharmaceutical and chemical industries."
This discussion has been archived. No new comments can be posted.

Synthetic Molecules Emulate Enzyme Behavior

Comments Filter:
  • Yay! (Score:3, Funny)

    by nhstar ( 452291 ) on Wednesday July 02, 2008 @09:21PM (#24039141)

    maybe it'll finally be cheap enough to ~cure~ things rather than just treat 'em.

    • Re: (Score:2, Insightful)

      by Tubal-Cain ( 1289912 )

      Pharmaceutical companies can only sell a cure once. They can sell treatments indefinitely.

      • Re: (Score:1, Flamebait)

        by bagsc ( 254194 )

        It's called "an installment plan." Most doctors offer them. The real question these days is how do you get your payment after the patient declares bankruptcy...

        • It's called "an installment plan." Most doctors offer them. The real question these days is how do you get your payment after the patient declares bankruptcy...

          Pound of flesh.

      • Re: (Score:3, Insightful)

        by Veggiesama ( 1203068 )

        Why does everybody always say this, hinting about the possibility of conspiracy theory cover-ups and withheld cures? Why is it so hard to believe that some people actually are searching for cures?

        If a company develops a cure for AIDS, cancer, or the common cold, then it stands to reason that the company is going to make a lot of money. While other companies are bumbling around with "treatments" and "therapies," this company is going to make a lot of short-term profit, and with the help of a patent office (o

        • Re:Yay! (Score:5, Interesting)

          by maxume ( 22995 ) on Thursday July 03, 2008 @07:19AM (#24041675)

          What's more satisfying: "we don't understand the disease well enough to cure it" or "those guys with more money than me are assholes"?

          What's interesting is that research into a lot of auto immune issues is actually starting to get somewhere, so we might actually start seeing cures for stuff in the next decade or two.

          • Comment removed based on user account deletion
            • Re: (Score:2, Informative)

              by sbeckstead ( 555647 )
              I appreciate your enthusiasm but that list contains not one single cure. Only prevention that is about 97% effective. Most also require booster shots to keep the protection active. If you actually contract one of those diseases we can make you as comfortable as possible and let it run it's course. But there are no cures. Pharms get paid for each person that receive those inoculations as well. Face it there is NO Financial incentive to cure a disease if you can make drugs to treat it.
        • by abushga ( 864910 ) *

          "If a company develops a cure for AIDS, cancer, or the common cold, then it stands to reason that the company is going to make a lot of money"

          Not necessarily. Orphan drugs are not patentable and therefore pharmaceutical companies have no incentive to pick up the huge costs of clinical trials for promising but dirt cheap molecules like dichloroacetate, 3-bromopyruvate, melatonin, to name but three.

          http://www.nytimes.com/2007/04/01/opinion/01moss.html?pagewanted=print [nytimes.com]

      • Give a man a fish, he eats for one day.

        Teach a man to fish, he eats for the rest of his life.

        Sell a man a fish, you're rich -- to heck with the man :

      • Indeed. However, in a market with both treatments and cures, people will probably pay more (as well as upfront) for the cure than for a treatment. It's kind of like the difference between buying software outright, and going for a subscription model. And you bet your bank account if people are offered the choice between $5/month for treatment for disease X and $5000 for the lifetime (or your money back) cure, people will typically rush to the cure.

        Let's take an example. 500 ./ers and myself get together for

  • Not just a boon, (Score:4, Interesting)

    by Anonymous Coward on Wednesday July 02, 2008 @09:21PM (#24039145)

    It would be the holy grail. Things like converting glucose to ATP in the body achieve ~70% efficiency. This is absolutely insane. If the scientists could accurately model and design the tertiary structure [wikipedia.org] of proteins at will then they could do things like making ethanol factories using minimal energy. This is extremely significant.

    • it gets hacked!

      I don't want to piss on a good idea, but powerful technologies can be bent to cause problems too.

    • Re:Not just a boon, (Score:5, Informative)

      by ruinevil ( 852677 ) on Wednesday July 02, 2008 @10:04PM (#24039369)

      Things like converting glucose to ATP in the body achieve ~70% efficiency.

      Glucose to ATP using glycolysis followed by cellular respiration using the electron transport, the most efficient process, is only about 40% efficient. The rest of the energy is released as heat, which is good for warm blooded creatures like ourselves. In babies, the brown fat makes cellular respiration even less efficient, which keeps them warm.

    • Re: (Score:2, Informative)

      Scientists have been able to design new proteins that can catalyze reactions. In two landmark papers just this year (De Novo Computational Design of Retro-Aldol Enzymes, Science 2008 319, 1387; Kemp elimination catalysts by computational enzyme design, Nature 2008 453, 190), David Baker's group at the University of Washington was able to computationally design two entirely new enzymes from scratch. Of course, there's still a lot of work to be done as these enzymes are not nearly as efficient as natural en
  • Spelling (Score:1, Offtopic)

    by jasonmanley ( 921037 )
    You spelt behaviour wrong. I joke, I joke ... I'm a kidder.
  • ..."nucular." Nucular.

    • by Dunbal ( 464142 )

      Go to bed, George...

    • Re: (Score:2, Informative)

      Flamebait?! Are you people kidding me?! That was a Homer Simpson quote! For the freaking love of Pete. Look, here's what was written:

      "They confirmed the shape of the molecules at each step using techniques such as nuclear magnetic resonance spectroscopy."

      Good freaking grief people. Get a sense of humor.

  • a hint of deja vu (Score:4, Insightful)

    by janneH ( 720747 ) on Wednesday July 02, 2008 @09:26PM (#24039187)
    Anyone remember catalytic antibodies - from 20 years ago - which also promised rapid engineering of "enzymes" for specific reactions. They were made by immunizing an animal with a transition state analog - under the theory that stabilizing the transition state would speed up reactions (since that is what enzymes do). Well, these "abzymes" completely revolutionized enzymology and biotechnology.....oh, wait...
    • Re: (Score:2, Insightful)

      by Rev_Frozt ( 108541 )

      I think this is fairly clearly overhyped. They are suggesting the following:

      We can construct more flexible molecules to use as catalysts. More flexible molecules interact more easily with other molecules in the environment. Unfortunately, by reacting without selectivity, it is more likely to find unexpected side-effects. This would have no place in drug design, though it could plausibly be used in very controlled environments. Realistically, people tend to want a catalyst to take A->B, not to take A

  • by BPPG ( 1181851 )
    Super-powered beef cows. No hormones added.
  • by Majik Sheff ( 930627 ) on Wednesday July 02, 2008 @09:30PM (#24039207) Journal

    How about a catalyst that takes CO2, H2O and photon energy and converts it into sugar and oxygen? Then we could use another catalyst to convert the sugar into alcohol. *Runs off to the patent office*

    • by BPPG ( 1181851 )

      That'd be fine if you just want pure alcohol. But there's a lot more to brewing drinkable beer or liquor than just feeding sugar to yeast.

      Unless you don't drink for the taste :-P

      • Re: (Score:2, Funny)

        by Anonymous Coward

        But there's a lot more to brewing drinkable beer or liquor than just feeding sugar to yeast.

        You old folk are always so picky. So long as it fucks me up, I'll drink/smoke/eat it :D

      • pfft, for beer, there're four ingredients, and one of them is water.

        • Re: (Score:2, Funny)

          by norpan ( 50740 )
          pfft, for beer, there're four ingredients, and one of them is water.

          Water, alcohol, taste and bubbles?

      • Pure alcohol is a fuel idiot. Far more valuable than yet another stupid way to get stupid.
  • by bperkins ( 12056 ) on Wednesday July 02, 2008 @09:37PM (#24039239) Homepage Journal

    That's what the Ohio State chemists find most exciting: the molecule does not maintain only one shape.

    See, that's how I'm different. They lost me at the Rockettes.

  • by slimjim8094 ( 941042 ) on Wednesday July 02, 2008 @10:15PM (#24039417)

    At some level, it was only a matter of time: put the molecules together in the right order, and (generally) the form the right shape when left to fold by themselves.

    But synthesis of enzymes and such has interesting ramifications for medicine (can't think of any enzyme-deficient diseases off the top of my head, but there must be some)

    Now what would be *really* interesting is if they could do proteins in general. That would open up a whole world of life-saving drugs.

  • I'm skeptical (Score:5, Insightful)

    by Sethumme ( 1313479 ) on Wednesday July 02, 2008 @10:55PM (#24039603)
    IANAC, but TFA seems to overstate the find and contains several misleading statements.

    First, they cannot "quickly produce a catalyst of a particular shape," but rather they are able to take one molecule and make it twist into either of two orientations. This isn't the holy grail of catalyst molecular engineering (to "give scientists a quick and easy way to get the catalyst that they want"); rather, it gives scientists a couple 'bonus' molecular shapes for each catalyst they synthesize. There is no indication that the ability to twist synthetic molecules means that scientists will have a significantly easier time discovering new catalysts that conform to the necessary shape. As TFA says, "[d]espite decades of research, scientists aren't sure exactly how this kind of propagation works." Why should searching for "a catalyst of a particular shape or function," involve any less trial and error than before?

    Moreover, the scientists claim that "as long as there is even a slight chemical preference for one of the hands. . . . [t]he 'flexible glove' will find a way to make a better fit, and so it will assist in specifically making one of the mirror image forms." Yet there is no proof that this "chemical preference" necessarily results in the ideal molecular arrangement of the catalyst. In fact, trying to synthesize a molecule that is capable of folding into multiple useful shapes in response to specific chemical environments seems more difficult than synthesizing individual catalysts to each handle one function independently.

    Again, I could be wrong, but I think this is only a very preliminary step in making more advanced synthetic catalysts, and not necessarily a way to design them faster.
    • by dlanod ( 979538 )

      Mod parent up. I read the summary and was thinking being able to design catalysts was a huge development if it was the case but was quite disappointed when finding out the actual details were extrapolating from a single data point. "Look, we got this tennis ball to bounce! Therefore all balls must bounce!", etc.

    • Actually it looks like you get more bang for your buck this way. You get several shapes at a time instead of one. Possibly faster if the shape you need is a right twist or mirror of the current one. It quickly goes beyond my understanding past that point.
  • Not that special... (Score:3, Informative)

    by comm2k ( 961394 ) on Wednesday July 02, 2008 @11:29PM (#24039765)
    As far as I can tell there are some factual errors - either because the reporter got it wrong or the researches are well.. just chemists and not biologists ;)

    Natural catalysts, such as enzymes in the human body that help us digest food, get around this problem by shape-shifting to suit the task at hand. (...)
    Natural catalysts reconfigure themselves over and over again in response to different chemical cues -- as enzymes do in the body, for example.

    Actually enzymes do a have a somewhat *fixed* fold for a specific (type of) reaction and don't just catalyse this then that etc. They can be highly selective for only one substance / functional chemical group or not. However they certainly don't reconfigure themselves (we're not talking about allosteric enzymes). The cell just produces a different set of enzymes to adjust to new conditions.

    In tests, the chemists caused the catalysts to twist one way or the other, either to form one chemical product or its mirror image.

    They better have this working 'error-free'. Having a mixture of both shapes can get you into big trouble (http://en.wikipedia.org/wiki/Thalidomide).

    "For many chemical reactions to work, molecules must be able to fit a catalyst like a hand fits a glove," RajanBabu said. "Our synthetic molecules are special because they're flexible. It doesn't matter if the hand is a small hand or a big hand, the 'glove' will change its shape to fit it, as long as there is even a slight chemical preference for one of the hands. The 'flexible glove' will find a way to make a better fit, and so it will assist in specifically making one of the mirror image forms."

    I'm not sure this is so good - wouldn't you want them to behave like enzymes aswell, being highly selective? And last but not least there is no comparison offered to *real* enzymes in terms of 'speed' and what kind of reactions besides fatty acid hydrogenation are possible.

    • Re: (Score:3, Informative)

      I'm sorry, I just can't let this one go... I may just be a lowly organic chemist, but there is nothing static about an enzyme. First, the obvious--conformational changes in response to pH, phosphorylation, ionic strength, etc. that turn on, turn off, or alter the functionality of an enzyme. And the even more obvious--the typical behavior of an enzyme is to alter conformation dynamically to stabilize transition states which lowers the activation barrier between two thermodynamic minima--the definition of a

      • soooo..... uber efficient enzymatic production of hydrogen from simple stocks (i.e. water) or is this tech completely inapplicable (HS chem ~ 25yrs ago)
      • by comm2k ( 961394 )
        You're right about what you're talking about (stabilization of transition state etc.).
        What I meant is that they don't just start catalyzing a new (type of) reaction - if there are entirely different substrates the cell will just adapt to this with a different set of enzymes - the existing enzymes wont automagically "shape-shift to suit the task at hand" to quote the original article.
  • would be a boom for the pharmaceutical and chemical industries ?

  • theres a WINE joke here...

"I'm a mean green mother from outer space" -- Audrey II, The Little Shop of Horrors

Working...